Abstract:BACKGROUND:Stem cell transplantation offers a promising treatment for heart failure. Recent studies show that both c-kit positive cardiac stem cells (CSCs) and bone marrow-derived mesenchymal stem cells (BM-MSCs) are good candidates for stem cell therapy to treat heart failure; however, the exact mechanism of stem cell therapy in improving cardiac function of ischemic cardiomyopathy is not fully known. Our objective was to test our hypothesis that CSCs and/or BM-MSCs repair the damaged heart by boosting post-myocardial infarction (MI) angiogenesis in a paracrine manner. METHODS AND RESULTS:We isolated and purified CSCs and BM-MSCs from rats. Intramyocardial injections of CSCs and/or BM-MSCs were performed at 28 days after MI. We applied cardiac ultrasound and histological analysis to evaluate the effect of cell therapy on cardiac function and cardiac remodeling. In vivo donor cell transplantation experiments showed that CSCs and/or BM-MSCs improved cardiac function after MI and reduced infarct size. However, in vivo cell tracking experiments showed that minimal donor cells remained in the myocardium after cell transplantation. Our further in vitro and in vivo experiments showed that transplantation of CSCs enhanced the expression of pro-angiogenic factors and boosted post-MI angiogenesis in the myocardium in a paracrine manner, which in part contributed to the effect of CSCs on cardiac recovery after MI. CSCs and BM-MSCs synergistically inhibited CSC/BM-MSC apoptosis and enhanced their proliferation in a paracrine manner. This resulted in a larger number of transplanted cells remaining in the post-MI myocardium after coinjection of CSCs and BM-MSCs, and therefore the accumulation of more pro-angiogenic factors in the heart tissue compared to transplantation of CSCs or MSCs alone. Consequently, transplantation of both CSCs and BM-MSCs was superior to transplantation of either CSCs or BM-MSCs alone to boost post-MI angiogenesis and improve cardiac function after MI. CONCLUSION:C-kit+ CSC and/or BM-MSC transplantation can improve cardiac function after MI in a paracrine manner. Coinjection of both CSCs and BM-MSCs improves cardiac function more significantly than CSC or BM-MSC transplantation alone in a paracrine manner by improving the engraftment of donor cells and boosting the expression of multiple pro-angiogenic factors.

Mesenchymal stem cells and cardiac repair.

Mesenchymal stem cell therapy for heart disease

Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease

Repair Mechanisms of Bone Marrow Mesenchymal Stem Cells in Myocardial Infarction

Biological Characters of Mesenchymal Stem Cells and Their Potential Functions for Cardiovascular Repair

Mesenchymal stem cell mediates cardiac repair through autocrine, paracrine and endocrine axes

Mesenchymal Stem Cells Promote Cardiac Muscle Repair Via Enhanced Neovascularization

Cardiac Cell Therapy: Insights into the Mechanisms of Tissue Repair

The Potential of Mesenchymal Stem Cell-Derived Exosomes in Cardiac Repair

Cardiac-derived stem cell-based therapy for heart failure: progress and clinical applications.

The therapeutic potential of mesenchymal stem cells for cardiovascular diseases

Mesenchymal Stromal Cell-Derived Exosomes in Cardiac Regeneration and Repair

Mesenchymal Stem Cell-Derived Exosomal microRNAs in Cardiac Regeneration

Mesenchymal stem cell-derived exosomes: a possible therapeutic strategy for repairing heart injuries

The development of autologous mesenchymal stem cell transplantation in the treatment of myocardial infarction

Mesenchymal Stem Cell Exosomes in the Treatment of Myocardial Infarction: a Systematic Review of Preclinical In Vivo Studies

Mesenchymal Stem Cells for Cardiac Regenerative Therapy: Optimization of Cell Differentiation Strategy

C-Kit Positive Cardiac Stem Cells and Bone Marrow-Derived Mesenchymal Stem Cells Synergistically Enhance Angiogenesis and Improve Cardiac Function After Myocardial Infarction in a Paracrine Manner.

Mesenchymal stem cells for cardiac repair: are the actors ready for the clinical scenario?

Stem Cell-Based Therapy in Cardiac Repair after Myocardial Infarction: Promise, Challenges, and Future Directions

Genetically modified mesenchymal stromal cells: a cell-based therapy offering more efficient repair after myocardial infarction